{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:28:37Z","timestamp":1793878117900,"version":"4.7.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T00:00:00Z","timestamp":1587081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T00:00:00Z","timestamp":1587081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00403-020-02068-z","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T17:03:14Z","timestamp":1587142994000},"page":"383-388","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Tacrolimus (FK506) ointment combined with Nb-UVB could activate both hair follicle (HF) and dermal melanocyte precursors in vitiligo: the first histopathological and clinical study"],"prefix":"10.1007","volume":"313","author":[{"given":"Yvon","family":"Gauthier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Almasi-Nasrabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Cario-Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Pain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Rakhshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Ghalamkarpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,17]]},"reference":[{"key":"2068_CR1","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.cell.2009.07.049","volume":"139","author":"I Adameyko","year":"2009","unstructured":"Adameyko I, Lallemand F, Aquino JB, Pereira JA, Topilko P (2009) Schwann cell precursors from nerve innervation are a cellular origin of cellular origin of melanocytes in skin. Cell 139:366\u2013379","journal-title":"Cell"},{"key":"2068_CR2","first-page":"123","volume":"149","author":"A Baldo","year":"2014","unstructured":"Baldo A, Lodi G, Di Caterino P, Monfrecola G (2014) Vitiligo, Nb-UVB and tacrolimus: our experience in Naples. G Ital Dermatol Venereol 149:123\u2013130","journal-title":"G Ital Dermatol Venereol"},{"key":"2068_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s13287-018-0956-4","volume":"9","author":"B Bellei","year":"2018","unstructured":"Bellei B, Migliano E, Tedesco M et al (2018) Adipose tissue-derived extracellular fraction characterization: biological and clinical considerations in regenerative medicine. Stem Cell Res Ther 9:207\u2013225","journal-title":"Stem Cell Res Ther"},{"key":"2068_CR4","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/med.21426","volume":"37","author":"SA Birlea","year":"2017","unstructured":"Birlea SA, Costin GE, Roop DR, Norris DA (2017) Trends in regenerative medecine: repigmentation in vitiligo through melanocyte stem cells mobilization. Med Res Rev 37:907\u2013935","journal-title":"Med Res Rev"},{"key":"2068_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.det.2016.11.015","volume":"35","author":"SA Birlea","year":"2017","unstructured":"Birlea SA, Goldstein NP, Norris DA (2017) Repigmentation through melanocyte regeneration in vitiligo. Dermatol Clin 35:205\u2013218","journal-title":"Dermatol Clin"},{"key":"2068_CR6","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/jid.2014.527","volume":"135","author":"M Cavalie","year":"2014","unstructured":"Cavalie M, Ezzedine K, Fontas E et al (2014) Maintenance therapy of adult vitiligo with 0.1% tacrolimus ointment: a randomized, double blind, placebo-controlled study. J Invest Dermatol 135:970\u2013974","journal-title":"J Invest Dermatol"},{"key":"2068_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/1523-1747.ep12480997","volume":"97","author":"J Cui","year":"1991","unstructured":"Cui J, Shen LY, Wang GC (1991) Role of hair follicles in the repigmentation of vitiligo. J invest Dermatol 97:410\u2013416","journal-title":"J invest Dermatol"},{"key":"2068_CR8","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/01.EHX.0000489999.79064.71","volume":"39","author":"Z El Maadawi","year":"2016","unstructured":"El Maadawi Z, Fawzy MM, Gabri H (2016) In vitro differentiation of adipose-derived stem cells into melanocyte lineage: a possible new alternative treatment for vitiligo. Egypt J Histol 39:260\u2013268","journal-title":"Egypt J Histol"},{"key":"2068_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4103\/0019-5154.57604","volume":"54","author":"R Falabella","year":"2009","unstructured":"Falabella R (2009) Vitiligo and the melanocyte reservoir. Indian J Dermatol 54:313\u2013318","journal-title":"Indian J Dermatol"},{"key":"2068_CR10","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/jid.2015.59","volume":"135","author":"M Fukunaga-Kalabis","year":"2015","unstructured":"Fukunaga-Kalabis M, Hristova DM, Wang JX et al (2015) Uv-induced Wnt7a in the human skin microenvironment specifies the fate of neural crest-like cells via suppression of Notch. J Invest Dermatol 135:1521\u20131532","journal-title":"J Invest Dermatol"},{"key":"2068_CR11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1600-0560.2007.00881.x","volume":"35","author":"B Gleason","year":"2008","unstructured":"Gleason B, Crum CP, Murphy G (2008) Expression patterns of MITF during human cutaneous embryogenesis. J Cutan Pathol 35:615\u2013622","journal-title":"J Cutan Pathol"},{"key":"2068_CR12","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/pcmr.12375","volume":"28","author":"JD Glover","year":"2015","unstructured":"Glover JD, Knolle S, Wells KL et al (2015) Maintenance of distinct melanocyte populations in the interfollicular epidermis. Pigm Cell Melanoma Res 28:476\u2013480","journal-title":"Pigm Cell Melanoma Res"},{"key":"2068_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jaad.2003.12.031","volume":"51","author":"PE Grimes","year":"2004","unstructured":"Grimes PE, Morris R, Avaniss-Aghani E (2004) Topical Tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J Am Acad Dermatol 51:52\u201361","journal-title":"J Am Acad Dermatol"},{"key":"2068_CR14","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1038\/jid.2015.372","volume":"135","author":"JE Harris","year":"2015","unstructured":"Harris JE (2015) Melanocyte regeneration in vitiligo requires WNT beneath their wings. J Invest Dermatol 135:2921\u20132923","journal-title":"J Invest Dermatol"},{"key":"2068_CR15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2340\/00015555-1740","volume":"94","author":"A Hartmann","year":"2014","unstructured":"Hartmann A, L\u00f6hberg L, Keikavoussi P et al (2014) Treatment of generalised vitiligo with tacrolimus 0.1% ointment vs. UVB intense pulsed light phototherapy: a pilot study. Acta Derm Venereol 94:585\u2013587","journal-title":"Acta Derm Venereol"},{"key":"2068_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14216","author":"T Hirobe","year":"2018","unstructured":"Hirobe T, Enami H (2018) Activation of melanoblasts and melanocytes after treatment with monochromatic excimer light and narrowband\u2014ultraviolet B of skin of vitiligo patients. Int J Dermatol. https:\/\/doi.org\/10.1111\/ijd.14216","journal-title":"Int J Dermatol"},{"key":"2068_CR17","doi-asserted-by":"publisher","first-page":"407079","DOI":"10.1155\/2012\/407079","volume":"2012","author":"J Hoerter","year":"2012","unstructured":"Hoerter J, Bradley P, Casillas A et al (2012) Extrafollicular dermal melanocyte stem cells and melanoma. Stem Cells Int 2012:407079","journal-title":"Stem Cells Int"},{"key":"2068_CR18","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/j.1346-8138.2010.01124.x","volume":"38","author":"D Juan","year":"2011","unstructured":"Juan D, Qianxi X, Zhou C, Jianzhong Z (2011) Clinical efficacy and safety of tacrolimus ointment in patients with vitiligo. J Dermatol 38:1092\u20131094","journal-title":"J Dermatol"},{"key":"2068_CR19","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/pcmr.12480","volume":"29","author":"HY Jung","year":"2016","unstructured":"Jung HY, Eok-Soo OH (2016) FK506 positively regulates the migratory potential of melanocyte-derived cells by enhancing syndecan-2 expression. Pigment Cell Melanoma Res 29:434\u2013343","journal-title":"Pigment Cell Melanoma Res"},{"key":"2068_CR20","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/j.1365-2133.2006.07467.x","volume":"155","author":"HY Kang","year":"2006","unstructured":"Kang HY, Choi YM (2006) FK506 increases pigmentation and migration of human melanocytes. Br J Dermatol 155:1037\u20131040","journal-title":"Br J Dermatol"},{"key":"2068_CR21","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1365-2133.2005.06739.x","volume":"153","author":"CC Lan","year":"2005","unstructured":"Lan CC, Chen GS, Chiou MH et al (2005) FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo. Br J Dermatol 153:498\u2013505","journal-title":"Br J Dermatol"},{"key":"2068_CR22","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1517\/14712598.2014.935331","volume":"14","author":"JH Lee","year":"2014","unstructured":"Lee JH, Fisher DE (2014) Melanocyte stem cells as potential therapeutic in skin disorders. Expert Opin Biol 14:1569\u20131579","journal-title":"Expert Opin Biol"},{"key":"2068_CR23","first-page":"0696","volume":"2019","author":"JH Lee","year":"2019","unstructured":"Lee JH, Kwon HS, Jung HM et al (2019) Treatment outcomes of topical calcineurin inhibitor therapy for patients with vitiligo. JAMA Dermatol 2019:0696","journal-title":"JAMA Dermatol"},{"key":"2068_CR24","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1242\/jcs.061598","volume":"123","author":"L Li","year":"2010","unstructured":"Li L, Fukanaga-Kalabis M, Hong Yu et al (2010) Human dermal stem cells differentiate into functional epidermal melanocytes. J Cell Sci 123:853\u2013560","journal-title":"J Cell Sci"},{"key":"2068_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1346-8138.2009.00774.x","volume":"37","author":"YH Lo","year":"2010","unstructured":"Lo YH, Cheng GS, Huang CC et al (2010) Efficacy and safety of topical tacrolimus for the treatment of face and neck vitiligo. J Dermatol 37:125\u2013129","journal-title":"J Dermatol"},{"key":"2068_CR26","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1600-0781.2010.00540.x","volume":"26","author":"I Majid","year":"2010","unstructured":"Majid I (2010) Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? Photodermatol Photoimmunol Photomed 26:230\u2013234","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2068_CR27","first-page":"4740709","volume":"2017","author":"A Owczarczyk-Saczoneka","year":"2017","unstructured":"Owczarczyk-Saczoneka A, Wocior A, Placek W, Maksymowicz W, Wojtkiewicz J (2017) The use of adipose derived stem cells in selected skin diseases (Vitiligo, Alopecia and nonhealing wounds). Stem cells 2017:4740709","journal-title":"Stem cells"},{"key":"2068_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0190-9622(03)00786-2","volume":"50","author":"D Parsad","year":"2004","unstructured":"Parsad D, Pandhi R, Dogra S, Kumar B (2004) Clinical study of repigmentation patterns with different treatment modalities. J Am Acad Dermatol 50:63\u201367","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2068_CR29","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/exd.13807","volume":"28","author":"T Razmi","year":"2018","unstructured":"Razmi T, Parsad D (2018) Vitiligo surgery a journey from tissues via cells to the stems. Exp Dermatol 28(6):690\u2013694. https:\/\/doi.org\/10.1111\/exd.13807","journal-title":"Exp Dermatol"},{"key":"2068_CR30","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1038\/jid.2015.335","volume":"135","author":"C Regazzetti","year":"2015","unstructured":"Regazzetti C, Joly F, Marty C et al (2015) Transcriptional Analysis of vitiligo skin reveals the alteration of WNT pathway: a promising target for repigmenting vitiligo patients. J Invest Dermatol 135:3105\u20133114","journal-title":"J Invest Dermatol"},{"key":"2068_CR31","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1684\/ejd.2009.0779","volume":"19","author":"G Stinco","year":"2009","unstructured":"Stinco G, Picirillo F, Forcione M et al (2009) An open randomized study to compare narrow band UVB, and topical tacrolimus in the treatment of vitiligo. Eur J Dermatol 19:588\u2013593","journal-title":"Eur J Dermatol"},{"key":"2068_CR32","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1365-2133.2009.09217.x","volume":"161","author":"ZA Taher","year":"2009","unstructured":"Taher ZA, Lauzon G, Maguiness S, Dytoc MT (2009) Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus. Br J Dermatol 161:654\u2013659","journal-title":"Br J Dermatol"},{"key":"2068_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1365-2133.2012.11197.x","volume":"168","author":"A Taieb","year":"2013","unstructured":"Taieb A, Alomar A, B\u00f6hm M et al (2013) Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol 168:5\u201319","journal-title":"Br J Dermatol"},{"key":"2068_CR34","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/archderm.139.5.571","volume":"139","author":"LB Travis","year":"2003","unstructured":"Travis LB, Weinberg JM, Silverberg NB (2003) Successful treatment of vitiligo with 0.1% Tacrolimus ointment. Arch Dermatol 139:571\u2013574","journal-title":"Arch Dermatol"},{"key":"2068_CR35","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/pcmr.12134","volume":"26","author":"CD Van Raamsdonk","year":"2013","unstructured":"Van Raamsdonk CD, Deo M (2013) Links between Schwann cells and melanocytes in development and disease. Pigment Cell Melanoma Res 26:634\u2013645","journal-title":"Pigment Cell Melanoma Res"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02068-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-020-02068-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02068-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T16:04:12Z","timestamp":1622909052000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-020-02068-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,17]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2068"],"URL":"https:\/\/doi.org\/10.1007\/s00403-020-02068-z","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,17]]},"assertion":[{"value":"12 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}